Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A synergistic interaction between PRMT5 and LSD1 inhibitors in AML. | Sci Adv | 2026 | 41894488 | PubTator, text mining | PubMed |
| Measurable residual disease testing in acute myeloid leukemia: current state, foundational models, and tools for future development. | Cancer Metastasis Rev | 2026 | 41894068 | PubTator, text mining | PubMed |
| The human branchpoint-interacting stem-loop sequence and structure regulates U2 snRNA expression, branchpoint recognition, and the transcriptome. | Nucleic Acids Res | 2026 | 41885209 | PubTator, text mining | PubMed |
| Molecular Genetic Demonstration of the Evolution of Transformed Mycosis Fungoides: A Clinicopathological and Molecular Case Study. | J Cutan Pathol | 2026 | 41873173 | PubTator, text mining | PubMed |
| Cancer-associated SF3B1 mutation suppresses DNA repair by disrupting the organization of nuclear actin network. | Cell Death Dis | 2026 | 41864997 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| Preliminary Safety and Efficacy of Navitoclax Plus Ruxolitinib in Janus Kinase Inhibitor-Naïve Patients With Myelofibrosis From the Multicenter, Open-Label, Phase 2 Study (REFINE). | Hematol Oncol | 2026 | 41846295 | PubTator, text mining | PubMed |
| [How I diagnose and treat chronic myelomonocytic leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | 41839624 | PubTator, text mining | PubMed |
| [Chinese guidelines for diagnosis and treatment of myelodysplastic neoplasms (2026)]. | Zhonghua Xue Ye Xue Za Zhi | 2026 | 41839623 | PubTator, text mining | PubMed |
| Unlocking the undruggable spliceosome: generative AI and structural dynamics in cancer therapy. | Front Cell Dev Biol | 2026 | 41836299 | PubTator, text mining | PubMed |
| Prognostic significance of CUX1 genomic deletion in myelodysplastic neoplasms. | Ann Hematol | 2026 | 41824036 | PubTator, text mining | PubMed |
| Acute myeloid leukaemia (AML) harbouring KMT2A-PTD: should it be considered as a myelodysplasia-related abnormality? | J Clin Pathol | 2026 | 41819800 | PubTator, text mining | PubMed |
| TP53-mutated myelodysplastic syndromes and acute myeloid leukemia: a comprehensive overview of targeted approaches. | Front Oncol | 2026 | 41809820 | PubTator, text mining | PubMed |
| Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changes. | Blood Neoplasia | 2026 | 41798677 | PubTator, text mining | PubMed |
| Exosome-delivered bioactive molecules regulate macrophage polarization in atherosclerosis and myocardial infarction: mechanisms and therapeutic potential. | Front Cardiovasc Med | 2026 | 41798608 | PubTator, text mining | PubMed |
| Preliminary evidence for the integration of CNAs, CN-LOH and mutational profiles into the prognostic stratification of elderly patients with NPM1-mutated acute myeloid leukemia. | Oncol Lett | 2026 | 41797886 | PubTator, text mining | PubMed |
| Prognostic impact of myelodysplasia-related gene mutations in ELN-2022 favorable-risk acute myeloid leukemia subtypes. | Ann Med | 2026 | 41797681 | PubTator, text mining | PubMed |
| Proteomic insights into the invasiveness and tumor progression of non-functioning pituitary adenomas: A scoping review. | J Neuroendocrinol | 2026 | 41795170 | PubTator, text mining | PubMed |
| Clonal haematopoiesis in chronic lymphocytic leukaemia: Biology, inflammaging and clinical implications in the era of targeted therapy. | Clin Transl Med | 2026 | 41793184 | PubTator, text mining | PubMed |
| RNA localization to nuclear speckles follows splicing logic. | Nucleic Acids Res | 2026 | 41787512 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=3